On December 9, 2025, Moleculin Biotech, Inc. agreed to a warrant exercise inducement offer, allowing holders to exercise 727,969 existing warrants at a reduced price of $6.63, generating approximately $6.8 million in proceeds. Additionally, they will issue new warrants for 2,610,823 shares of common stock with a five-year term.